Advertisement

Topics

CODA Biotherapeutics launches with $19mm Series A round

15:40 EDT 12 Oct 2018 | Elsevier Business Intelligence

Neurological disease-focused CODA Biotherapeutics Inc. (chemogenetic gene therapy platform) launched with a $19mm Series A ro...

Original Article: CODA Biotherapeutics launches with $19mm Series A round

NEXT ARTICLE

More From BioPortfolio on "CODA Biotherapeutics launches with $19mm Series A round"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...